The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

 CELSCISci Corp  (CVM) Trade Now »     Rate CVM  -  Discuss CVM  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
87.5%
Top:
0.0%
Rate CVM:



Who've Rated CVM All   |   Bullish   |   Bearish   |   Hold

Name Rank Rating Return Start Closed
johngo390 N/A Positive -37.84% 03/30/10 --
Obi-wankenobi_main
mbmalone N/A Positive -60.08% 10/30/09 --
Mikerun
Mike Havrilla 73% Negative +62.67% 10/29/09 --
donkimchi N/A Positive -70.34% 10/06/09 --
mzalowitz N/A Positive -77.47% 10/02/09 --
ireneak N/A Positive -74.93% 09/24/09 --
carrier5 N/A Positive -79.11% 09/21/09 --
dilly N/A Positive -71.17% 09/17/09 --
Olof Thomas N/A Positive -69.45% 09/17/09 --
sld sld N/A Positive -69.45% 09/17/09 --
money9 N/A Positive -43.21% 08/28/09 --
Tom N/A Positive -35.99% 08/27/09 --
zerohealth N/A Positive +48.84% 08/21/09 08/27/09
listad N/A Positive -16.80% 08/10/09 --
shashi249 N/A Positive -19.36% 08/02/09 --
Jon Anthony N/A Positive +77.19% 06/02/09 06/09/09
orbitant 53% Positive -40.71% 02/06/08 --
Joe I 32% Positive -33.85% 11/07/07 --


ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on CVM

Visit streetinsider.com


Discussion Wall + Add  

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   1 reply

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre
+   0 replies


More Resources

Graphic_arrow1 About CELSCISci Corp - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch